We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
251
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.46M | 0.1% |
138,240
+230
| +0.2% | +$7.01K |
|
252
Jack in the Box
JACK
$263M
| $4.43M | 0.09% |
45,020
+2,710
| +6% | +$280K |
|
253
Stratasys
SSYS
$695M
| $4.43M | 0.09% |
189,920
-34,390
| -15% | -$885K |
|
254
Benchmark Electronics
BHE
$3.01B
| $4.41M | 0.09% |
136,450
+11,830
| +9% | +$381K |
|
255
Dell
DELL
$284B
| $4.4M | 0.09% |
+256,624
| New | +$4.7M |
|
|
IRBT
256
DELISTED
iRobot
IRBT
| $4.38M | 0.09% |
52,110
-31,430
| -38% | -$2.71M |
|
|
PF
257
DELISTED
Pinnacle Foods, Inc.
PF
| $4.37M | 0.09% |
+73,630
| New | +$4.4M |
|
258
Avnet
AVT
$7.38B
| $4.37M | 0.09% |
112,320
-370,919
| -77% | -$14.7M |
|
259
Unisys
UIS
$238M
| $4.35M | 0.09% |
339,986
-61,577
| -15% | -$749K |
|
|
AD
260
Array Digital Infrastructure
AD
$2.95B
| $4.32M | 0.09% |
112,816
+19,590
| +21% | +$758K |
|
261
Scholastic
SCHL
$857M
| $4.29M | 0.09% |
98,401
-3,901
| -4% | -$169K |
|
|
ABMD
262
DELISTED
Abiomed Inc
ABMD
| $4.28M | 0.09% |
29,888
+550
| +2% | +$73.9K |
|
263
MasTec
MTZ
$28.4B
| $4.24M | 0.09% |
93,930
+41,760
| +80% | +$1.81M |
|
264
AXIS Capital
AXS
$8.45B
| $4.19M | 0.09% |
64,777
+24,310
| +60% | +$1.59M |
|
265
Lam Research
LRCX
$400B
| $4.15M | 0.09% |
+293,430
| New | +$4.3M |
|
266
Amgen
AMGN
$201B
| $4.14M | 0.09% |
24,042
-8,150
| -25% | -$1.33M |
|
267
Southwest Gas
SWX
$6.73B
| $4.13M | 0.09% |
56,550
+45,232
| +400% | +$3.62M |
|
|
APC
268
DELISTED
Anadarko Petroleum
APC
| $4.12M | 0.09% |
90,790
+27,070
| +42% | +$1.44M |
|
269
Adobe
ADBE
$84.3B
| $4.06M | 0.09% |
28,710
+11,310
| +65% | +$1.55M |
|
|
SNBR
270
DELISTED
Sleep Number
SNBR
| $4.04M | 0.09% |
113,921
+33,580
| +42% | +$1M |
|
271
Stryker
SYK
$122B
| $4.04M | 0.09% |
29,120
-23,090
| -44% | -$3.17M |
|
|
AAWW
272
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $4.04M | 0.09% |
77,480
-3,711
| -5% | -$196K |
|
273
New York Times
NYT
$11.4B
| $4.02M | 0.09% |
227,180
+81,580
| +56% | +$1.34M |
|
274
Cencora
COR
$59.4B
| $4M | 0.09% |
42,320
-26,400
| -38% | -$2.35M |
|
|
VRTV
275
DELISTED
VERITIV CORPORATION
VRTV
| $3.94M | 0.08% |
87,653
+70,445
| +409% | +$3.23M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.